Stuttgart - Delayed Quote EUR

MeiraGTx Holdings PLC (328.SG)

4.8000
+0.0200
+(0.42%)
At close: May 8 at 9:31:41 PM GMT+2
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
33,279
33,279
14,017
15,920
37,701
Cost of Revenue
23,791
23,791
0
--
--
Gross Profit
9,488
9,488
14,017
--
--
Operating Expense
173,700
173,700
151,078
132,275
110,459
Operating Income
-164,212
-164,212
-137,061
-116,355
-72,758
Net Non Operating Interest Income Expense
-9,127
-9,127
-10,973
-4,169
-76
Other Income Expense
25,548
25,548
64,007
-9,091
-6,727
Pretax Income
-147,791
-147,791
-84,027
-129,615
-79,561
Tax Provision
0
--
--
--
--
Net Income Common Stockholders
-147,791
-147,791
-84,027
-129,615
-79,561
Diluted NI Available to Com Stockholders
-147,791
-147,791
-84,027
-129,615
-79,561
Basic EPS
-1.20
-2.12
-1.49
-2.87
-1.80
Diluted EPS
-1.20
-2.12
-1.49
-2.87
-1.80
Basic Average Shares
65,610.4150
69,822.3530
56,486.5250
45,177.8570
44,139.6550
Diluted Average Shares
65,610.4150
69,822.3530
56,486.5250
45,177.8570
44,139.6550
Total Operating Income as Reported
-164,212
-164,212
-137,061
-116,355
-72,758
Total Expenses
197,491
197,491
151,078
132,275
110,459
Net Income from Continuing & Discontinued Operation
-147,791
-147,791
-84,027
-129,615
-79,561
Normalized Income
-173,339
-173,339
-147,535
-120,524
-72,834
Interest Income
4,145
4,145
2,272
777
212
Interest Expense
13,272
13,272
13,245
4,946
288
Net Interest Income
-9,127
-9,127
-10,973
-4,169
-76
EBIT
-134,519
-134,519
-70,782
-124,669
-79,273
EBITDA
-121,838
-121,838
-57,058
-116,066
-71,400
Reconciled Cost of Revenue
23,791
23,791
0
--
--
Reconciled Depreciation
12,681
12,681
13,724
8,603
7,873
Net Income from Continuing Operation Net Minority Interest
-147,791
-147,791
-84,027
-129,615
-79,561
Total Unusual Items Excluding Goodwill
25,548
25,548
63,508
-9,091
-6,727
Total Unusual Items
25,548
25,548
63,508
-9,091
-6,727
Normalized EBITDA
-147,386
-147,386
-120,566
-106,975
-64,673
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 10/20/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

25I.SG ImmuPharma PLC
0.0295
-1.67%
 
BT3.BE Lineage Cell Therapeutics Inc
0.3840
+2.67%
 
22Z.SG Zealand Pharma A/S
59.96
-0.40%
 
XUPB.F Genfit S.A.
3.8000
-1.04%
 
SCP.F Scancell Holdings plc
0.0950
-1.04%
 
6XC.F Soleno Therapeutics, Inc.
64.05
+2.89%
 
GNFTF Genfit S.A.
3.5400
0.00%
 
2L9.SG Blueprint Medicines Corp
88.12
+1.66%
 
PI3.DU Gubra AS
51.00
-1.26%
 
AYJ.HA Valneva SE
2.8500
-1.99%